Currently out of the existing stock ratings of John Kreger, 1 are a BUY (100%).

John Kreger

Work Performance Price Targets & Ratings Chart

Analyst John Kreger, currently employed at WILLIAM BLAIR,

Most recent stock forecast was given on CVET, Covetrus at 29-Jan-2026.

Wall Street Analyst John Kreger

Analyst best performing recommendations are on CVET (COVETRUS).
REPH Recro Pharma SDC SmileDirectClub SNCE Science 37 Holdings XRAY Dentsply Sirona CVET Covetrus ALGN Align Technology SYNH Syneos Health

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy

$5

$4.21 (532.91%)

$18

5 years 5 months 18 days ago
(11-Aug-2020)

2/4 (50%)

$3.59 (41.69%)

106

Buy Since 12-May-2020

$12

$11.21 (1418.99%)

$18

5 years 8 months 17 days ago
(12-May-2020)

3/6 (50%)

$7.12 (145.90%)

127

Buy Since 19-Dec-2016

6 years 2 months 3 days ago
(26-Nov-2019)

3/3 (100%)

$2.32 (40.35%)

197

Hold Since 25-Mar-2019

$6.73

$5.94 (751.90%)

6 years 10 months 4 days ago
(25-Mar-2019)

1/4 (25%)

$0.98 (17.04%)

10

Show more analysts

Please expand the browser size to see the chart

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?